Please login to the form below

Not currently logged in
Email:
Password:

diabetes alliance

This page shows the latest diabetes alliance news and features for those working in and with pharma, biotech and healthcare.

Merck & Co and Pfizer take aim at diabetes with trio of new drugs

Merck & Co and Pfizer take aim at diabetes with trio of new drugs

File ertugliflozin-based products with EU and US regulators. Merck &Co and Pfizer's four-year-old alliance in diabetes has reached fruition with the filing of three new products based ... A tougher pricing and reimbursement environment means

Latest news

  • IBM adds to healthcare capabilities with Truven buy IBM adds to healthcare capabilities with Truven buy

    That approach has already won Watson Health some partnerships with pharma companies, including a project with Novo Nordisk on a digital platform to help manage diabetes, an eHealth alliance with Teva

  • J&J and Hanmi collaborate on diabetes and obesity J&J and Hanmi collaborate on diabetes and obesity

    Alliance worth up to$915m. Johnson and Johnson have entered into an alliance with Hanmi Pharmaceuticals to develop new treatments for diabetes and obesity. ... The alliance involves the development and commercialisation of oxyntomodulin-based therapies,

  • FDA clears Jardiance combo for type 2 diabetes FDA clears Jardiance combo for type 2 diabetes

    Combination treatment Synjardy is fifth drug to come from Boehringer/Lilly diabetes alliance. ... Synjardy is the fifth FDA-approved medicine to emerge from the Boehringer/Lilly diabetes alliance pipeline in the last four years, according to Paul Fonteyne

  • Medtronic and Samsung partner on diabetes device Medtronic and Samsung partner on diabetes device

    Alliance will develop app to monitor glucose and insulin information. Medical technology company Medtronic has teamed up with Samsung Electronics to improve diabetes management for patients living with the disease. ... Announced at the American Diabetes

  • AstraZeneca and its diabetes plans AstraZeneca and its diabetes plans

    Both AZ and BMS had been involved in a diabetes alliance since 2007 and have developed the DPP-4 inhibitor Onglyza (saxagliptin), the saxagliptin/metformin combination product Kombiglyze and the SGLT2 ... This was then expanded in 2012 when the alliance

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest Intelligence

  • Pharma deals during June 2014 Pharma deals during June 2014

    It was a busy month for Medtronic as the company also announced the signature of a memorandum of understanding with Sanofi to enter into a global strategic alliance in diabetes. ... It is intended to base the alliance on an open innovation model with

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    This was then expanded in 2012 when the alliance acquired Amylin, gaining the rights to a portfolio of products for type 2 diabetes, including the exenatide franchise (Byetta and Bydureon). ... The recent development with the BMS alliance confirms AZ's

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Virgo Health names US head Virgo Health names US head

    This includes the diabetes alliance between Boehringer Ingelhiem and Lilly, as well as Merck's respiratory portfolio.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics